Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World June 28, 2013 Helen Carmichael	European research funding deal on the Horizon The informal accord, reached on 25 June, just days before the end of the Irish presidency of the EU, offers a helping hand to scientists from poorer member states, in an attempt to balance the program's 'focus on excellence.'
Chemistry World December 4, 2014 Ned Stafford	Plan to divert EU research cash into investment fund gets chilly response from scientists The proposal would see the money moved from Horizon 2020 into a new investment fund to bolster Europe's economy and create jobs.
Pharmaceutical Executive October 1, 2012 Peter O'Donnell	Richard Bergstrom -- Europe's Medicine Man The new head of the European Federation of Pharmaceutical Industries and Associations faces a Promethean challenge: selling the merits of costly science and innovation in an era of bristling competition, fiscal crisis, and declining demographics.
Pharmaceutical Executive August 1, 2014	EFPIA's 'Integrated Strategy' in Europe: Out of the Frying Pan, Into the Fire? Industry's grand vision for reshaping the life sciences in Europe may ultimately prove to be a lost cause.
Chemistry World December 5, 2011 Ned Stafford	Europe plans large cash injection for research Horizon 2020 has been crafted to emphasize cooperation between academic researchers and business with the goal of 'turning scientific breakthroughs into innovative products and services'.
Chemistry World April 27, 2015 Ned Stafford	European parliament refuses to back diversion of research cash Key European parliament committees have overwhelmingly rejected a proposal to divert euro 2.7 billion of research funding to help finance a new EU-wide economic stimulus package.
Pharmaceutical Executive July 1, 2011	Holy Surge of Enthusiasm! While Europe's EFPIA preaches about embracing change, much remains to be done to prove the adjustment in philosophy.
Chemistry World June 1, 2015 Ned Stafford	Scientists hail partial victory on efforts to block cuts to European research programme All-night negotiations between European politicians led to the protection of key areas of the EU's research program.
Pharmaceutical Executive October 1, 2006 Sarah Houlton	Global Report: Please Come Back Health authorities in Europe are working hard to reestablish their countries as preferred locations for pharma's R&D facilities. Fortunately, they've got a blueprint: China.
Pharmaceutical Executive September 1, 2014 William Looney	Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.
Chemistry World October 28, 2015 Ned Stafford	Falling Horizon success rates worry research community The report from the European commission has caused concern among the continent's university and business research community and EU officials.
Pharmaceutical Executive October 1, 2014 William Looney	IDEAlogue for Innovation Professor Fabio Pammolli, a leading European economist and policy advisor to the key EU institutions, outlines the current dilemma facing health and pharma regulators in Europe today.
Pharmaceutical Executive September 1, 2014	Peril, Not Progress on Transatlantic Trade Deal Pharma hopes for a deal are fading as the once-hot TTIP talks seem to be on the fizzle in Europe.
Pharmaceutical Executive September 1, 2012	Patients Wade Into the Pricing Debate Europe's fiscal crisis is becoming a new rallying cry for patient groups, but regional unity is still elusive.
Chemistry World July 15, 2014 Emma Stoye	Public--private research partnerships to tackle Europe's big problems The European Union will invest euro 7.3 billion in seven newly launched public -- private partnerships as part of its Horizon2020 research funding program.
Pharmaceutical Executive June 1, 2011	A Lack of Information Why has the EU still not managed to update its rules on information about medicines?
Chemistry World August 23, 2012 Simon Campbell	Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth.
Chemistry World January 21, 2015 Ned Stafford	euro 2.7bn research cuts to fund Europe's stimulus package unveiled The European commission has revealed which research programs will be cut to fund its stimulus package.
Pharmaceutical Executive January 1, 2012	Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
Pharmaceutical Executive November 1, 2006 Sarah Houlton	Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need.
Pharmaceutical Executive June 1, 2014	Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector."
Pharmaceutical Executive February 1, 2012	Industry/Gov't R&D Support: So Far So Good The EU's Innovative Medicines Initiative is helping to invigorate new drug development, but there are still many hurdles to tackle before its promise is realized.
Fast Company Pavithra Mohan	Europe To Nix Mobile Roaming Charges By 2017 The European Union would put an end to mobile roaming charges starting in June 2017, according to Agence France-Presse.
Chemistry World July 24, 2012 Nuala Moran	Plan to tackle EU funding disparity The final shape of the 80 billion euro Horizon 2020 research fund continues to be a bone of contention among budgetary conservatives and poorer member states that fear that they won't see any of this money.
Chemistry World February 27, 2008 Arthur Rogers	European Institute of Technology to Open in 2010 A flurry of activity in Brussels and Strasbourg has cleared the way for a 2010 launch of the European Institute of Technology (EIT).
Pharmaceutical Executive April 1, 2011	Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm.
Pharmaceutical Executive September 1, 2005 Sarah Houlton	Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation.
Pharmaceutical Executive June 1, 2012	Europe Responds to Medical Device 'Crisis' A recent medical device controversy in France has pushed European health ministers to agree on a crisis management program for the troubled sector.
Pharmaceutical Executive December 1, 2011	Europe's Transparency Directive Revisited The effect on pharma of the EU's Transparency Directive has been overly constraining, but will the mooted revisions offer any room to maneuver?
Pharmaceutical Executive January 21, 2014 Comer & Upton	Pharm Exec's Annual Industry Outlook 2014 For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive; muddling through is so yesterday.
Pharmaceutical Executive April 1, 2014	Whatever Happened To Faster Reimbursement For Generics In Europe? The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.
Chemistry World May 23, 2006 Arthur Rogers	Budget Shortfall Threatens FP7 An agreement on European Union budgets signed on May 17 confirms that EU research investment between 2007 and 2013 will fall 20 billion euros short of the 67.8 billion euros suggested by the European commission.
Pharmaceutical Executive December 1, 2010	The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs.
Chemistry World December 11, 2015 Anthony King	All boats to be lifted by Irish science strategy A new science strategy crafted by the Irish government is promising to boost national research funding to 2.5% of GNP, up from 1.8%, by 2020.
Chemistry World February 25, 2015 Matthew Gunther	Nobel laureates warn on European science funding cuts A letter has been sent by 27 Nobel laureates to Jean-Claude Juncker, the European commission president, criticizing the proposed budget cuts.
Chemistry World July 20, 2010 Ned Stafford	Cash boost for EU research The European Commission has revealed details of its largest investment in research and innovation to date, announcing a funding package worth 6.4 billion ( 5.4 billion).
Pharmaceutical Executive August 1, 2012 Carol Ann Williams	Data Exclusivity: Making the Case As the scope and complexity of registration information demanded by regulators increases, protection of that know-how has become a critical differentiator in the "go" or "no go" calculation on whether to invest in a new medicine.
Pharmaceutical Executive September 1, 2013	T-TIPing the Balance in Industry's Favor By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.
Pharmaceutical Executive August 1, 2008 Sarah Houlton	Jumping the Gun The Association of the British Pharmaceutical Industry and the British government have come up with a solution for price regulation that isn't as bad as the industry had feared.
Pharmaceutical Executive October 1, 2014	Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point.
Chemistry World April 30, 2010 Sarah Houlton	EU research faces radical overhaul The European Commission has responded to calls from researchers to cut red tape in EU funding processes and has also proposed radical changes to EU research funding policies, moving towards linking payment to results.
Pharmaceutical Executive May 1, 2011 Julian Upton	UK Stakeholders Have Their Say on Value-Based Pricing The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance.
Chemistry World December 1, 2006 Arthur Rogers	EU Approves 54 Billion Euro Science Plan The European Parliament has finally approved the Seventh Framework Research Program, which promises to distribute 54 billion euro of science funding over the next seven years.
Pharmaceutical Executive May 1, 2007 Sarah Houlton	Global Report: Pure and Simple The european union is set to overhaul the way it monitors drug safety to help make sense of a decentralized system that has been criticized for being ineffective. Will the EC's upcoming drug-safety plan be just what the doctor ordered or end up an indecent proposal?
Chemistry World November 28, 2012 Ned Stafford	Scientists come together to fight EU budget cuts As politicians continue to debate sharp reductions to the next seven year EU budget, scientists are joining together and loudly urging political leaders to keep their budgetary knives away from research funding.
Pharmaceutical Executive August 1, 2011 William Looney	Innovation at Pfizer A Q and A with Kristin Peck, the drug maker's Executive Vice President, Worldwide Business Development and Innovation.
Pharmaceutical Executive April 1, 2011	How US Health Reform Is Hitting Canada Canada's Russell Williams, of Rx&D, talks about the impact of US health reform on his role as chief spokesman for the country's R&D industry.
Chemistry World March 1, 2014 Bibiana Campos Seijo	European collaborations EuCheMS, the European Association for Chemical and Molecular Sciences, provides a single voice for chemistry in Europe.
Chemistry World June 18, 2008 Ananyo Bhattacharya	Deal on NHS drugs set to trim pharma profits An agreement between the UK government and the pharmaceutical industry will cut around five per cent off the cost of medicines sold to the National Health Service
Pharmaceutical Executive September 1, 2012 Stan Bernard	The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model.